IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics

  • Authors:
    • Biyun Qian
    • Dionyssios Katsaros
    • Lingeng Lu
    • Emilie Marion Canuto
    • Chiara Benedetto
    • Alicia Beeghly-Fadiel
    • Herbert Yu
  • View Affiliations

  • Published online on: January 1, 2011     https://doi.org/10.3892/or_00001062
  • Pages: 203-213
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

High expression of insulin-like growth factor-II (IGF-II) in epithelial ovarian cancer is associated with aggressive disease and poor prognosis. IGF-II transcription is initiated from multiple promoters. Promoter-specific expression is regulated by DNA methylation, which is often dysregulated in cancer. Here, the effects of promoter-specific methylation on IGF-II expression are investigated in ovarian cancer. Fresh tumor samples were collected from 211 patients for analyses of IGF-II promoter methylation using methylation-specific PCR, and of promoter-specific expression of IGF-II mRNA with qRT-PCR, as well as tissue levels of IGF-II peptide with an ELISA. Cox regression analysis was performed to assess IGF-II methylation and expression in association with progression-free and overall survival. DNA methylation was high in IGF-II promoters 2 (P2, 64.2%) and 3 (P3, 52.1%) and low in promoter 4 (P4, 9.8%). High methylation was associated with low mRNA expression in a promoter-specific manner. P3 methylation and expression appeared to be critical in ovarian cancer compared to other promoters. While methylation in an individual promoter was not associated with the disease, a methylation pattern involving P2 and P3 was significantly different among patients with distinct tumor grade, debulking results, residual tumor size and treatment response. The methylation pattern was also associated with disease progression. The study suggests that DNA methylation regulates IGF-II promoter-specific expression in ovarian cancer and the regulation may play a role in disease progression. Assessing methylation patterns in IGF-II promoters may have clinical implications.

Related Articles

Journal Cover

January 2011
Volume 25 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qian B, Katsaros D, Lu L, Canuto EM, Benedetto C, Beeghly-Fadiel A and Yu H: IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics . Oncol Rep 25: 203-213, 2011.
APA
Qian, B., Katsaros, D., Lu, L., Canuto, E.M., Benedetto, C., Beeghly-Fadiel, A., & Yu, H. (2011). IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics . Oncology Reports, 25, 203-213. https://doi.org/10.3892/or_00001062
MLA
Qian, B., Katsaros, D., Lu, L., Canuto, E. M., Benedetto, C., Beeghly-Fadiel, A., Yu, H."IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics ". Oncology Reports 25.1 (2011): 203-213.
Chicago
Qian, B., Katsaros, D., Lu, L., Canuto, E. M., Benedetto, C., Beeghly-Fadiel, A., Yu, H."IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics ". Oncology Reports 25, no. 1 (2011): 203-213. https://doi.org/10.3892/or_00001062